Providing Regulatory Submissions in Electronic Format --Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 23, 2020
December 23, 2020
30645a17-5f24-407a-9837-05c1ed1d46be
Related Documents
Providing Regulatory Submissions in Electronic Format — Certain Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications Guidance for Industry
Guidance DocumentSeptember 13, 2024Center for Drug Evaluation and Research
Providing Regulatory Submissions in Electronic Format — Submissions Under Section 745A(a) of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentDecember 18, 2014Center for Drug Evaluation and Research
Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentDecember 10, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox